Clinical Trials Browser

Phase 3 × Active not recruiting × Albumin-Bound Paclitaxel × Clear all

Non Small Cell Lung Cancer NSCLC

NCT04895358 2026-03-11

KEYNOTE-B49

Phase 3 Active not recruiting

340 enrolled

Breast

Parkinson Disease 4, Autosomal Dominant Lewy Body, Breast Neoplasms, Neoplasm Metastasis

NCT05771480 2026-02-23

TOURMALINE

Phase 3 Active not recruiting

142 enrolled

Gastrointestinal

Biliary Tract Neoplasms

NCT04251533 2026-02-13

EPIK-B3

Phase 3 Active not recruiting

137 enrolled 21 charts

Breast

Triple Negative Breast Neoplasms

NCT06132958 2026-01-09

TroFuse-005

Phase 3 Active not recruiting

710 enrolled

Gynecologic

Endometrial Neoplasms

NCT06212752 2025-11-12

MK-3475A-D77

Phase 3 Active not recruiting

39 enrolled 21 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05840211 2025-10-03

ASCENT-07

Phase 3 Active not recruiting

654 enrolled

Breast

Breast Neoplasms

NCT05722015 2025-09-11

MK-3475A-D77

Phase 3 Active not recruiting

377 enrolled 17 charts 1 FDA

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05382299 2025-09-05

ASCENT-03

Phase 3 Active not recruiting

623 enrolled

Breast

Triple Negative Breast Neoplasms

NCT04879368 2025-07-17

INTEGRATEIIb

Phase 3 Active not recruiting

450 enrolled

Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

NCT04956692 2024-12-03

MK-3475-A86

Phase 3 Active not recruiting

531 enrolled 18 charts

Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

Clinical Trials

POSEIDON

KEYNOTE-B49

TOURMALINE

EPIK-B3

TroFuse-005

MK-3475A-D77

ASCENT-07

MK-3475A-D77

ASCENT-03

INTEGRATEIIb

MK-3475-A86